Rapid Response of Stem Cells and Immune Cells for Efficacy

Part of paid clinical trials in Klamath Falls, Oregon.

Sponsor
Natural Immune Systems Inc
Study ID
NCT07127705
Status
Recruiting
Apply to this trial

Conditions

  • Stem Cell Surveillance

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Accepted

Interventions

  • Placebo — DIETARY_SUPPLEMENT
    2 capsules
  • Chaga Mushroom — DIETARY_SUPPLEMENT
    2 capsules
  • Ginseng extract — DIETARY_SUPPLEMENT
    2 capsules
  • Olive extract — DIETARY_SUPPLEMENT
    2 capsules
  • Potassium Hydrogen Glucarate — DIETARY_SUPPLEMENT
    2 capsules

Study Details

The goal for this clinical trial is to compare rapid effects of four products on stem cells, immune activation, and mitochondrial function. A double-blind, placebo-controlled, cross-over study design will be used.

Key Dates

Start date
May 21, 2025
Status verified
Aug 2025
Primary completion
Aug 27, 2025
Completion
Oct 3, 2025

Study Design

Enrollment
24 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION

Arms

  • Experimental: Crossover group 1, randomized
    Crossover study: Participants consume a test product on each of the five clinic days, at least 1 week apart, allowing for 1 week wash-out period between each product. Participants will consume each of the 4 active test products versus placebo over 5 weeks. The order of interventions for this group is A, C, B, D, E.
  • Experimental: Crossover group 2, randomized
    Crossover study: Participants consume a test product on each of the five clinic days, at least 1 week apart, allowing for 1 week wash-out period between each product. Participants will consume each of the 4 active test products versus placebo over 5 weeks. The order of interventions for this group is E, A, C, B, D.
  • Experimental: Crossover group 3, randomized
    Crossover study: Participants consume a test product on each of the five clinic days, at least 1 week apart, allowing for 1 week wash-out period between each product. Participants will consume each of the 4 active test products versus placebo over 5 weeks. The order of interventions for this group is D, E, A, C, B.
  • Experimental: Crossover group 4, randomized
    Crossover study: Participants consume a test product on each of the five clinic days, at least 1 week apart, allowing for 1 week wash-out period between each product. Participants will consume each of the 4 active test products versus placebo over 5 weeks. The order of interventions for this group is B, C, D, A, E.

Primary Outcome Measure

Stem cell trafficking [ Time Frame: Baseline. 1 hour, 2 hours, and 3 hours after ingestion of study drug ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
NIS LabsKlamath FallsOregon97601
Gitte S. Jensen, PhD
[email protected]
541-884-0112

Find similar trials in Klamath Falls, OR

By research site
NIS Labs· Klamath Falls, OR

Related Studies